Engineering cardiac tissue in vivo from human adipose-derived stem cells

Biomaterials

Volumn 31, Issue 8, 2010, Pages 2236-2242

  Choi, Yu Suk ^a,b   Matsuda, Ken ^a   Dusting, Gregory J ^a,b   Morrison, Wayne A ^a,b   Dilley, Rodney J ^a,b,c  

^a Bernard O'Brien Institute of Microsurgery   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Australian Tissue Engineering Centre   (Australia)

Author keywords

Adipose derived stem cells; Cardiac tissue engineering; Cardiomyocyte; Cardiomyogenic differentiation

Indexed keywords

ADIPOGENIC; ADIPOSE DERIVED STEM CELLS; CARDIAC MARKERS; CARDIAC MUSCLES; CARDIAC REPAIR; CARDIAC TISSUE ENGINEERING; CARDIAC TISSUES; CARDIOMYOCYTES; CO-IMPLANTATION; ENGINEERED TISSUES; HUMAN ADIPOSE; IMMUNOSTAINING; IN-VIVO; SMOOTH MUSCLE CELLS; TISSUE CONSTRUCTS; VASCULAR STRUCTURES; VASCULARISATION;

ENGINEERING; HEART; MUSCLE; STEM CELLS;

TISSUE ENGINEERING;

ADIPOGENESIS; ADIPOSE TISSUE CELL; ADULT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HEART MUSCLE CELL; HEART VOLUME; HUMAN; HUMAN CELL; IMPLANTATION; IN VIVO STUDY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; STEM CELL; TISSUE ENGINEERING; TISSUE GROWTH;

ADIPOSE TISSUE; ADULT; ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; HUMANS; MIDDLE AGED; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING;

RATTUS;

EID: 74449090381     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.11.097     Document Type: Article

References (40)

1. World Health Organization. Available from: http://www.who.int/mediacentre/factsheets/fs317/en/index/html.
2. Caspi O., Lesman A., Basevitch Y., Gepstein A., Arbel G., Habib I.H., et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 100 (2007) 263-272
3. Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
4. Meyer G.P., Wollert K.C., Lotz J., Steffens J., Lippolt P., Fichtner S., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 (2006) 1287-1294
5. Menasche P., Hagege A.A., Scorsin M., Pouzet B., Desnos M., Duboc D., et al. Myoblast transplantation for heart failure. Lancet 357 (2001) 279-280
6. Menasche P., Alfieri O., Janssens S., McKenna W., Reichenspurner H., Trinquart L., et al. The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117 (2008) 1189-1200
7. Reinecke H., Zhang M., Bartosek T., and Murry C.E. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 100 (1999) 193-202
8. Muller-Ehmsen J., Peterson K.L., Kedes L., Whittaker P., Dow J.S., Long T.I., et al. Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation 105 (2002) 1720-1726
9. Bradley J.A., Bolton E.M., and Pedersen R.A. Stem cell medicine encounters the immune system. Nat Rev Immunol 2 (2002) 859-871
10. Lensch M.W., Schlaeger T.M., Zon L.I., and Daley G.Q. Teratoma formation assays with human embryonic stem cells: a rationale for one type of human-animal chimera. Cell Stem Cell 1 (2007) 253-258
11. Shimizu T., Yamato M., Kikuchi A., and Okano T. Cell sheet engineering for myocardial tissue reconstruction. Biomaterials 24 (2003) 2309-2316
12. Shimizu T., Sekine H., Isoi Y., Yamato M., Kikuchi A., and Okano T. Long-term survival and growth of pulsatile myocardial tissue grafts engineered by the layering of cardiomyocyte sheets. Tissue Eng 12 (2006) 499-507
13. Sekine H., Shimizu T., Yang J., Kobayashi E., and Okano T. Pulsatile myocardial tubes fabricated with cell sheet engineering. Circulation 114 (2006) I87-I93
14. Furuta A., Miyoshi S., Itabashi Y., Shimizu T., Kira S., Hayakawa K., et al. Pulsatile cardiac tissue grafts using a novel three-dimensional cell sheet manipulation technique functionally integrates with the host heart, in vivo. Circ Res 98 (2006) 705-712
15. Birla R.K., Huang Y.C., and Dennis R.G. Development of a novel bioreactor for the mechanical loading of tissue-engineered heart muscle. Tissue Eng 13 (2007) 2239-2248
16. Zimmermann W.H., Schneiderbanger K., Schubert P., Didie M., Munzel F., Heubach J.F., et al. Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90 (2002) 223-230
17. Zimmermann W.H., Melnychenko I., and Eschenhagen T. Engineered heart tissue for regeneration of diseased hearts. Biomaterials 25 (2004) 1639-1647
18. Naito H., Melnychenko I., Didie M., Schneiderbanger K., Schubert P., Rosenkranz S., et al. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 114 (2006) I72-I78
19. Ott H.C., Matthiesen T.S., Goh S.K., Black L.D., Kren S.M., Netoff T.I., et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 14 (2008) 213-221
20. Kofidis T., Lebl D.R., Martinez E.C., Hoyt G., Tanaka M., and Robbins R.C. Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation 112 (2005) I173-I177
21. Zimmermann W.H., Melnychenko I., Wasmeier G., Didie M., Naito H., Nixdorff U., et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12 (2006) 452-458
22. Eschenhagen T., and Zimmermann W.H. Engineering myocardial tissue. Circ Res 97 (2005) 1220-1231
23. Morritt A.N., Bortolotto S.K., Dilley R.J., Han X., Kompa A.R., McCombe D., et al. Cardiac tissue engineering in an in vivo vascularized chamber. Circulation 115 (2007) 353-360
24. Choi Y.S., Matsuda K., Falkenberg K., Arunothayaraj S., Han X.L., Dusting G.J., et al. Cardiac tissue engineering using adipose-derived stem cells. Hypertension 53 (2009) 035
25. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7 (2001) 211-228
26. Choi Y.S., Cha S.M., Lee Y.Y., Kwon S.W., Park C.J., and Kim M. Adipogenic differentiation of adipose tissue derived adult stem cells in nude mouse. Biochem Biophys Res Commun 345 (2006) 631-637
27. Planat-Benard V., Menard C., Andre M., Puceat M., Perez A., Garcia-Verdugo J.M., et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 94 (2004) 223-229
28. Gaustad K.G., Boquest A.C., Anderson B.E., Gerdes A.M., and Collas P. Differentiation of human adipose tissue stem cells using extracts of rat cardiomyocytes. Biochem Biophys Res Commun 314 (2004) 420-427
29. Strem B.M., Zhu M., Alfonso Z., Daniels E.J., Schreiber R., Beygui R., et al. Expression of cardiomyocytic markers on adipose tissue-derived cells in a murine model of acute myocardial injury. Cytotherapy 7 (2005) 282-291
30. Valina C., Pinkernell K., Song Y.H., Bai X., Sadat S., Campeau R.J., et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J 28 (2007) 2667-2677
31. Planat-Benard V., Silvestre J.S., Cousin B., Andre M., Nibbelink M., Tamarat R., et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109 (2004) 656-663
32. Cao Y., Sun Z., Liao L., Meng Y., Han Q., and Zhao R.C. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun 332 (2005) 370-379
33. Wang T., Xu Z., Jiang W., and Ma A. Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int J Cardiol 109 (2006) 74-81
34. Thangarajah H., Vial I.N., Chang E., El-Ftesi S., Januszyk M., Chang E.I., et al. IFATS collection: adipose stromal cells adopt a proangiogenic phenotype under the influence of hypoxia. Stem Cells 27 (2009) 266-274
35. Rehman J., Traktuev D., Li J., Merfeld-Clauss S., Temm-Grove C.J., Bovenkerk J.E., et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109 (2004) 1292-1298
36. Rubina K., Kalinina N., Efimenko A., Lopatina T., Melikhova V., Tsokolaeva Z., et al. Adipose stromal cells stimulate angiogenesis via promoting progenitor cell differentiation, secretion of angiogenic factors, and enhancing vessel maturation. Tissue Eng Part A 15 (2009) 2039-2050
37. Lokmic Z., Stillaert F., Morrison W.A., Thompson E.W., and Mitchell G.M. An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered construct. FASEB J 21 (2007) 511-522
38. Hofer S.O., Mitchell G.M., Penington A.J., Morrison W.A., RomeoMeeuw R., Keramidaris E., et al. The use of pimonidazole to characterise hypoxia in the internal environment of an in vivo tissue engineering chamber. Br J Plast Surg 58 (2005) 1104-1114
39. Traktuev D.O., Prater D.N., Merfeld-Clauss S., Sanjeevaiah A.R., Murphy M., Johnstone B.H., et al. Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells. Circ Res 104 (2009) 1410-1420
40. Thomas G.P., Hemmrich K., Abberton K.M., McCombe D., Penington A.J., Thompson E.W., et al. Zymosan-induced inflammation stimulates neo-adipogenesis. Int J Obes (Lond) 32 (2008) 239-248